These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32479983)

  • 1. Expression of nuclear progesterone receptors (nPRs), membrane progesterone receptors (mPRs) and progesterone receptor membrane components (PGRMCs) in the human endometrium after 6 months levonorgestrel low dose intrauterine therapy.
    Sletten ET; Smaglyukova N; Ørbo A; Sager G
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105701. PubMed ID: 32479983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data on RT-qPCR assay of nuclear progesterone receptors (nPR), membrane progesterone receptors (mPR) and progesterone receptor membrane components (PGRMC) from human uterine endometrial tissue and cancer cells of the Uterine Cervix.
    Smaglyukova N; Sletten ET; Ørbo A; Sager G
    Data Brief; 2020 Aug; 31():105923. PubMed ID: 32671144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system.
    Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF
    Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of intrauterine levonorgestrel use on the expression of c-JUN, oestrogen receptors, progesterone receptors and Ki-67 in human endometrium.
    Salmi A; Pakarinen P; Peltola AM; Rutanen EM
    Mol Hum Reprod; 1998 Dec; 4(12):1110-5. PubMed ID: 9872360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of levonorgestrel-releasing intrauterine system on endometrial estrogen and progesterone receptors in patients with endometrial hyperplasia].
    Weng M; Li L; Feng S; Xie M; Hong S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1350-4. PubMed ID: 22985581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system.
    Orbo A; Arnes M; Pettersen I; Larsen K; Hanssen K; Moe B
    Acta Obstet Gynecol Scand; 2010 Nov; 89(11):1438-46. PubMed ID: 20955098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA expression of insulin-like growth factor-I (IGF-I) is suppressed and those of IGF-II and IGF-binding protein-1 are constantly expressed in the endometrium during use of an intrauterine levonorgestrel system.
    Rutanen EM; Salmi A; Nyman T
    Mol Hum Reprod; 1997 Sep; 3(9):749-54. PubMed ID: 9357999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone receptor in Norplant endometrium.
    Lau TM; Witjaksono J; Rogers PA
    Hum Reprod; 1996 Oct; 11 Suppl 2():90-4. PubMed ID: 8982750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery.
    Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF
    Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).
    Kim MK; Seong SJ; Lee TS; Ki KD; Lim MC; Kim YH; Kim K; Joo WD
    Jpn J Clin Oncol; 2015 Oct; 45(10):980-2. PubMed ID: 26206899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
    Haimovich S; Checa MA; Mancebo G; Fusté P; Carreras R
    Menopause; 2008; 15(5):1002-4. PubMed ID: 18451744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
    Kim MK; Seong SJ; Kim JW; Jeon S; Choi HS; Lee IH; Lee JH; Ju W; Song ES; Park H; Ryu HS; Lee C; Kang SB
    Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium.
    Burton KA; Henderson TA; Hillier SG; Mason JI; Habib F; Brenner RM; Critchley HO
    Hum Reprod; 2003 Dec; 18(12):2610-7. PubMed ID: 14645180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidates for membrane progestin receptors--past approaches and future challenges.
    Zhu Y; Hanna RN; Schaaf MJ; Spaink HP; Thomas P
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Nov; 148(4):381-9. PubMed ID: 18602498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive ability of estrogen receptor (ER), progesterone receptor (PR), COX-2, Mlh1, and Bcl-2 expressions for regression and relapse of endometrial hyperplasia treated with LNG-IUS: a prospective cohort study.
    Gallos ID; Devey J; Ganesan R; Gupta JK
    Gynecol Oncol; 2013 Jul; 130(1):58-63. PubMed ID: 23603367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia.
    Marnach ML; Butler KA; Henry MR; Hutz CE; Langstraat CL; Lohse CM; Casey PM
    J Womens Health (Larchmt); 2017 Apr; 26(4):368-373. PubMed ID: 27901412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in progesterone receptor membrane component 2 (PGRMC2) in the endometrium of macaques afflicted with advanced endometriosis.
    Keator CS; Mah K; Slayden OD
    Mol Hum Reprod; 2012 Jun; 18(6):308-19. PubMed ID: 22307145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-alpha and ER-beta) in human endometrial hyperplasia.
    Vereide AB; Kaino T; Sager G; Arnes M; Ørbo A
    Gynecol Oncol; 2006 May; 101(2):214-23. PubMed ID: 16325240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of progesterone receptor mRNA in the endometrium during the normal menstrual cycle and in Norplant users.
    Lau TM; Witjaksono J; Affandi B; Rogers PA
    Hum Reprod; 1996 Dec; 11(12):2629-34. PubMed ID: 9021364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.